Antibody–Drug Conjugates for Immunology
The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory...
Gespeichert in:
| Veröffentlicht in: | Journal of medicinal chemistry 2022-03, Vol.65 (6), p.4496-4499 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 4499 |
|---|---|
| container_issue | 6 |
| container_start_page | 4496 |
| container_title | Journal of medicinal chemistry |
| container_volume | 65 |
| creator | Dragovich, Peter S |
| description | The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory activity and unwanted systemic side effects. |
| doi_str_mv | 10.1021/acs.jmedchem.2c00339 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2638940663</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2638940663</sourcerecordid><originalsourceid>FETCH-LOGICAL-a278t-8e67f22169e465c315ac8179225b5e945e57c61cde3ed99c74c31845cd43ed253</originalsourceid><addsrcrecordid>eNp9kEtOwzAQhi0EoqVwA4S6hEWKPX7EWVblVakSG1hbruOUVklc7HiRHXfghpwEQ1uWrEaa-f4ZzYfQJcETgoHcahMmm8aW5s02EzAYU1ocoSHhgDMmMTtGQ4wBMhBAB-gshA1ODAF6igaUg-SpP0Q307ZbL13Zf3183vm4Gs9cu4kr3dkwrpwfz5smtq52q_4cnVS6DvZiX0fo9eH-ZfaULZ4f57PpItOQyy6TVuQVABGFZYIbSrg2kuQFAF9yWzBueW4EMaWltiwKk7PESMZNyVIDOB2h693erXfv0YZONetgbF3r1roYFAgqC4aFoAllO9R4F4K3ldr6daN9rwhWP5JUkqQOktReUopd7S_EZZr9hQ5WEoB3wG_cRd-mh__f-Q0lC3Wn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2638940663</pqid></control><display><type>article</type><title>Antibody–Drug Conjugates for Immunology</title><source>ACS Publications</source><creator>Dragovich, Peter S</creator><creatorcontrib>Dragovich, Peter S</creatorcontrib><description>The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory activity and unwanted systemic side effects.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.2c00339</identifier><identifier>PMID: 35285623</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2022-03, Vol.65 (6), p.4496-4499</ispartof><rights>2022 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a278t-8e67f22169e465c315ac8179225b5e945e57c61cde3ed99c74c31845cd43ed253</citedby><cites>FETCH-LOGICAL-a278t-8e67f22169e465c315ac8179225b5e945e57c61cde3ed99c74c31845cd43ed253</cites><orcidid>0000-0001-7372-2862</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c00339$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00339$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35285623$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dragovich, Peter S</creatorcontrib><title>Antibody–Drug Conjugates for Immunology</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory activity and unwanted systemic side effects.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kEtOwzAQhi0EoqVwA4S6hEWKPX7EWVblVakSG1hbruOUVklc7HiRHXfghpwEQ1uWrEaa-f4ZzYfQJcETgoHcahMmm8aW5s02EzAYU1ocoSHhgDMmMTtGQ4wBMhBAB-gshA1ODAF6igaUg-SpP0Q307ZbL13Zf3183vm4Gs9cu4kr3dkwrpwfz5smtq52q_4cnVS6DvZiX0fo9eH-ZfaULZ4f57PpItOQyy6TVuQVABGFZYIbSrg2kuQFAF9yWzBueW4EMaWltiwKk7PESMZNyVIDOB2h693erXfv0YZONetgbF3r1roYFAgqC4aFoAllO9R4F4K3ldr6daN9rwhWP5JUkqQOktReUopd7S_EZZr9hQ5WEoB3wG_cRd-mh__f-Q0lC3Wn</recordid><startdate>20220324</startdate><enddate>20220324</enddate><creator>Dragovich, Peter S</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7372-2862</orcidid></search><sort><creationdate>20220324</creationdate><title>Antibody–Drug Conjugates for Immunology</title><author>Dragovich, Peter S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a278t-8e67f22169e465c315ac8179225b5e945e57c61cde3ed99c74c31845cd43ed253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dragovich, Peter S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dragovich, Peter S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibody–Drug Conjugates for Immunology</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2022-03-24</date><risdate>2022</risdate><volume>65</volume><issue>6</issue><spage>4496</spage><epage>4499</epage><pages>4496-4499</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>The application of antibody–drug conjugates (ADCs) to fields outside of oncology is increasing but is still relatively uncommon. A recent publication describes the conjugation of glucocorticoid receptor modulators to antibodies as a means of improving the separation between desired anti-inflammatory activity and unwanted systemic side effects.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>35285623</pmid><doi>10.1021/acs.jmedchem.2c00339</doi><tpages>4</tpages><orcidid>https://orcid.org/0000-0001-7372-2862</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-2623 |
| ispartof | Journal of medicinal chemistry, 2022-03, Vol.65 (6), p.4496-4499 |
| issn | 0022-2623 1520-4804 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2638940663 |
| source | ACS Publications |
| title | Antibody–Drug Conjugates for Immunology |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T04%3A28%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibody%E2%80%93Drug%20Conjugates%20for%20Immunology&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Dragovich,%20Peter%20S&rft.date=2022-03-24&rft.volume=65&rft.issue=6&rft.spage=4496&rft.epage=4499&rft.pages=4496-4499&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.2c00339&rft_dat=%3Cproquest_cross%3E2638940663%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2638940663&rft_id=info:pmid/35285623&rfr_iscdi=true |